Gland Pharma Limited (GLAND) Share Analysis
NSE · Healthcare · Pharmaceuticals
Gland Pharma Limited (NSE: GLAND) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma. As of 14 Nov 2026, the share price was ₹3,334.00, P/E 43.9, ROE 10.7%.
Get the AI verdict on GLAND: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
GLAND chart with trendlines
Is GLAND a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Gland Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
GLAND key facts
| Price and valuation | |
|---|---|
| Share price | ₹3,334.00 |
| Market cap | ₹55,016 Cr |
| P/E ratio | 43.9 |
| P/B ratio | 5.15 |
| EPS | ₹74.96 |
| Book value per share | ₹648.00 |
| Dividend yield | 0.6% |
| 52-week range | |
| 52-week high | ₹3,374.00 |
| 52-week low | ₹1,573.60 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 45.75% |
| FIIs | 10.36% |
| DIIs | 33.21% |
| Public | 10.68% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.